IU Investigator Receives Warning Letter for Insufficient Corrective Action Plan

Clinical Trials Advisor
A A
The FDA issued a warning letter to Merrill Benson, a faculty member at Indiana University School of Medicine, over insufficient blood and panel testing of subjects observed at a clinical trial site following a Form 483.

To View This Article:

Login

Subscribe To Clinical Trials Advisor

Buy This Article Now

Add this article to your cart for $25.00